Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone Injection

Aurobindo Pharma arm bags USFDA nod for Plerixafor Injection

Ruchika Sharma25 July 2023 3:55 PM IST

Plerixafor injection is indicated in combination with granulocyte-colony stimulating factor to mobilize hematopoietic stem cells (HSCs) to the...

Biocon Biologics bribery case: Govt grants sanction to prosecute CDSCO joint drugs controller

Ruchika Sharma25 July 2023 2:30 PM IST

The arrests were made in June last year in the bribery case allegedly to waive the Phase 3 clinical trial of 'Insulin Aspart' injection, a product...

State-Wide Immunization Drive in Haryana Targets High-Risk Areas

Govt approves export of Serum Institute BCG vaccine to Canada

Ruchika Sharma25 July 2023 1:30 PM IST

The product is for intravesical instillation and is available from the Serum Institute in 40 mg and 80 mg presentations, the sources said.

DCGI approves AstraZeneca Dapagliflozin for heart failure treatment in adults

Ruchika Sharma25 July 2023 12:30 PM IST

New Delhi: AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, announced it has received extended indication approval from the...

Anuj Virmani becomes MD of JnJ MedTech India division

Ruchika Sharma25 July 2023 11:41 AM IST

Mumbai: Johnson & Johnson Private Limited has announced the appointment of Anuj Virmani as the Managing Director for its Johnson & Johnson...

Lupin Digital Health, The American College of Cardiology collaborate to deliver in home cardiovascular care with Digital Therapeutics in India

Ruchika Sharma25 July 2023 10:00 AM IST

As part of this collaboration, Lupin Digital Health will leverage ACC's CardioSmart platform, guidelines, and workbooks to guide healthcare...

HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuit

Gilead to discontinue Phase 3 ENHANCE study of Magrolimab plus Azacitidine in higher-risk MDS

Ruchika Sharma24 July 2023 4:45 PM IST

Foster City: Gilead Sciences, Inc. has announced that the Phase 3 ENHANCE study in higher-risk myelodysplastic syndromes (MDS) has been...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche Evrysdi gets CHMP recommendation for babies under two months old with spinal muscular atrophy

Ruchika Sharma24 July 2023 3:30 PM IST

Evrysdi is currently approved in the EU for the treatment of patients aged two months or older,

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

CHMP recommends nod of Merck Keytruda in combo with trastuzumab, chemotherapy to treat HER2-positive advanced GEJ adenocarcinoma expressing PD-L1

Ruchika Sharma24 July 2023 2:30 PM IST

Rahway:Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s Committee for Medicinal...

Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilities

Roche, Alnylam collaborate for hypertension therapy

Ruchika Sharma24 July 2023 12:29 PM IST

Under the terms of the agreement, Alnylam will receive an upfront payment of USD 310m and is eligible to receive development, regulatory and...

Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma

Bristol Myers Squibb gets positive CHMP opinion recommending nod for Opdivo for adjuvant treatment for Melanoma

Ruchika Sharma24 July 2023 11:22 AM IST

Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

UP STF Set to Name Pharma Firms in Multi-Crore Codeine Syrup Scam

Gambia 'advanced' in exploring legal action over toxic Indian cough syrup

Ruchika Sharma24 July 2023 10:00 AM IST

Families of 20 of the children have already sued the two companies as well as Gambian authorities.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok